Trials / Completed
CompletedNCT00239304
Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer
A Phase I/II Trial of ZD1839 (Iressa) Given Concurrently With Cisplatin and Radiotherapy in Patients With Locally Advanced Head and Neck Cancer
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the safety and tolerability of gefitinib in combination with cisplatin and radiation (3D-CRT or IMRT) in patients with locally advanced head and neck cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gefitinib | |
| DRUG | Cisplatin | |
| PROCEDURE | Radiotherapy |
Timeline
- Start date
- 2003-06-01
- Completion
- 2006-03-01
- First posted
- 2005-10-17
- Last updated
- 2007-12-18
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT00239304. Inclusion in this directory is not an endorsement.